The DOI matches its Crossref record; 317 of the 317 references it cites were found in a registry or an index.
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
Open accessAbstract
Evidence-based guidelines for the management of patients with methicillin-resistant Staphylococcus aureus (MRSA) infections were prepared by an Expert Panel of the Infectious Diseases Society of America (IDSA). The guidelines are intended for use by health care providers who care for adult and pediatric patients with MRSA infections. The guidelines discuss the management of a variety of clinical syndromes associated with MRSA disease, including skin and soft tissue infections (SSTI), bacteremia and endocarditis, pneumonia, bone and joint infections, and central nervous system (CNS) infections. Recommendations are provided regarding vancomycin dosing and monitoring, management of infections due to MRSA strains with reduced susceptibility to vancomycin, and vancomycin treatment failures.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–317 of 317
Arias, C. A., Vallejo, M., Reyes, J., Panesso, D., Moreno, J., Castañeda, E., Villegas, M. V., Murray, B. E., & Quinn, J. P. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.01886-07 · Cited by 121
Self-citationTreatment of community-acquired methicillin-resistant Staphylococcus aureus in children
MARCINAK, J. F., & Frank, A. L. (2003) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200306000-00014 · Cited by 121
Management of Methicillin‐ResistantStaphylococcus aureusBacteremia
Cosgrove, S. E., & Fowler, V. G. (2008) · Clinical Infectious Diseases · doi:10.1086/533595 · Cited by 118
Self-citationLinezolid in the Treatment of Osteomyelitis: Results of Compassionate Use Experience
Rayner, C. R., Baddour, L. M., Birmingham, M. C., Norden, C. W., Meagher, A. K., & Schentag, J. J. (2004) · Infection · doi:10.1007/s15010-004-3029-9 · Cited by 117
Moise, P. A., Smyth, D. S., El-Fawal, N., Robinson, D. A., Holden, P. N., Forrest, A., & Sakoulas, G. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm445 · Cited by 117
D’Agostino, R. S., Miller, D. C., Stinson, E. B., Mitchell, R. S., Oyer, P. E., Jamieson, S. W., Baldwin, J. C., & Shumway, N. E. (1985) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(10)60097-5 · Cited by 116
In vivo verification of in vitro model of antibiotic treatment of device-related infection
Blaser, J., Vergères, P., Widmer, A. F., & Zimmerli, W. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.5.1134 · Cited by 116
Rehm, S. J., Boucher, H. W., Levine, D. P., Campion, M., Eisenstein, B. I., Vigliani, G. A., Corey, G. R., & Abrutyn, E. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn372 · Cited by 114
Self-citationJang, H., Kim, S., Kim, K. H., Kim, C. J., Lee, S., Song, K., Jeon, J. H., Park, W. B., Kim, H. B., Park, S., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/600295 · Cited by 113
Raz, R. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00040041109010 · Cited by 113
Tsuji, B. T., & Rybak, M. J. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.7.2735-2745.2005 · Cited by 113
Self-citationFrequency of Infective Endocarditis Among Infants and Children With Staphylococcus aureus Bacteremia
Valente, A. M., Jain, R., Scheurer, M. A., Fowler, V. G., Corey, G. R., Bengur, A. R., Sanders, S. P., & Li, J. S. (2004) · PEDIATRICS · doi:10.1542/peds.2004-1152 · Cited by 112
Gandelman, K., Zhu, T., Fahmi, O. A., Glue, P., Lian, K., Obach, R. S., & Damle, B. D. (2010) · The Journal of Clinical Pharmacology · doi:10.1177/0091270010366445 · Cited by 111
Sia, I. G., & Berbari, E. F. (2006) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2006.08.014 · Cited by 110
Impact of Methicillin Resistance on Outcome of Staphylococcus aureus Ventilator-associated Pneumonia
Combes, A., Luyt, C. E., Fagon, J.-Y., Wollf, M., Trouillet, J., Gibert, C., & Chastre, J. E. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200403-346oc · Cited by 110
Conservative Management of Patients with Cerebrospinal Fluid Shunt Infections
Brown, E. M., Edwards, R. J., & Pople, I. K. (2006) · Neurosurgery · doi:10.1227/01.neu.0000204126.54417.46 · Cited by 110
Serotonin Syndrome and Linezolid
Wigen, C. L., & Goetz, M. B. (2002) · Clinical Infectious Diseases · doi:10.1086/340710 · Cited by 110
Shorr, A. F., Combes, A., Kollef, M. H., & Chastre, J. E. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000201885.57697.21 · Cited by 109
Cottagnoud, P., Pfister, M., Acosta, F., Cottagnoud, M., Flatz, L., Kühn, F., Müller, H.-P., & Stucki, A. N. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.10.3928-3933.2004 · Cited by 109
Lodise, T. P., McKinnon, P. S., Levine, D. P., & Rybak, M. J. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00101-07 · Cited by 107
Self-citationLong‐Term Outcome of Infective Endocarditis: The Impact of Early Surgical Intervention
Bishara, J., Leibovici, L., Gartman‐Israel, D., Sagie, A., Казаков, А. Д., Miroshnik, E., Ashkenazi, S., & Pitlik, S. D. (2001) · Clinical Infectious Diseases · doi:10.1086/323785 · Cited by 107
Clinical Experience with Daptomycin for the Treatment of Patients with Osteomyelitis
Lamp, K. C., Friedrich, L. V., Mendez-Vigo, L., et al. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.07.010 · Cited by 106
Lee, T. C., Carrick, M. M., Scott, B. G., Hodges, J. C., & Pham, H. Q. (2007) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2007.08.047 · Cited by 105
Tsuji, B. T., Rybak, M. J., Cheung, C. M., Amjad, M., & Kaatz, G. W. (2007) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2006.10.021 · Cited by 105
Self-citationCenizal, M. J., Skiest, D. J., Luber, S., Bedimo, R., Davis, P., Fox, P., Delaney, K., & Hardy, R. D. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00206-07 · Cited by 103
Wunderink, R. G., Mendelson, M. H., Somero, M. S., Fabian, T. C., May, A. K., Bhattacharyya, H., Leeper, K. V., & Solomkin, J. S. (2008) · CHEST Journal · doi:10.1378/chest.08-0011 · Cited by 103
Clinical failures of appropriately-treated methicillin-resistant Staphylococcus aureus infections
Dombrowski, J. C., & Winston, L. G. (2008) · Journal of Infection · doi:10.1016/j.jinf.2008.04.003 · Cited by 99
Grohs, P., Kitzis, M.-D., & Gutmann, L. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.1.418-420.2003 · Cited by 99
Robicsek, A. A., Beaumont, J. L., Thomson, R. B., Govindarajan, G., & Peterson, L. R. (2009) · Infection Control and Hospital Epidemiology · doi:10.1086/597550 · Cited by 98
Yusof, A., Engelhardt, A., Karlsson, A., Bylund, L., Vidh, P., Mills, K., Wootton, M., & Walsh, T. R. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00265-08 · Cited by 97
Rutar, T., Chambers, H. F. “., Crawford, J. B., Perdreau‐Remington, F., Zwick, O. M., Karr, M., Diehn, J. J., & Cockerham, K. P. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2006.03.031 · Cited by 93
Self-citationRomano, R., Lu, D., & Holtom, P. D. (2006) · PubMed Central · Cited by 93
Venous thrombosis and thromboembolism in children with osteomyelitis
Crary, S. E., Buchanan, G. R., Drake, C. E., & Journeycake, J. M. (2006) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2006.06.067 · Cited by 92
Elliott, D., Zaoutis, T., Troxel, A., Loh, A., & Keren, R. (2009) · Pediatrics · doi:10.1542/peds.2008-2428 · Cited by 91
Rose, W. E., Leonard, S. N., & Rybak, M. J. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00102-08 · Cited by 91
Self-citationOutcomes of treatment for hematogenous Staphylococcus aureus vertebral osteomyelitis in the MRSA ERA
Livorsi, D. J., Daver, N. G., Atmar, R. L., Shelburne, S. A., White, A. C., & Musher, D. M. (2008) · Journal of Infection · doi:10.1016/j.jinf.2008.04.012 · Cited by 89
Euba, G., Murillo, Ó., Sabé, N., Mascaró, J., Cabo, J., Pérez, A. P., Tubau, F., Verdaguer, R., Gudiol, F., & Ariza, J. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01504-08 · Cited by 88
Daptomycin Therapy for Invasive Gram-Positive Bacterial Infections in Children
Ardura, M. I., Mejías, A., Katz, K. S., Revell, P., McCracken, G. H., & Sánchez, P. J. (2007) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31814523f8 · Cited by 87
Gene heterogeneity for tetracycline resistance in Staphylococcus spp
Bismuth, R., Zilhão, R., Sakamoto, H., Guesdon, J.-L., & Courvalin, P. M. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.8.1611 · Cited by 86
Panton-Valentine Leukocidin and Staphyloccoccal Skin Infections in Schoolchildren1
Boubaker, K., Diebold, P., Blanc, D., Vandenesch, F., Praz, G., Dupuis, G., & Troillet, N. (2004) · Emerging infectious diseases · doi:10.3201/eid1001.030144 · Cited by 86
Penetration of rifampicin into the cerebrospinal fluid of adults with uninflamed meninges
Nau, R., Prange, H. W., Menck, S., Kolenda, H., Visser, K., & Seydel, J. K. (1992) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/29.6.719 · Cited by 85
USA300 is the Predominant Genotype Causing Staphylococcus aureus Septic Arthritis in Children
Carrillo-Marquez, M. A., Hultén, K. G., Hammerman, W. A., Mason, E. O., & Kaplan, S. L. (2009) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181adbcfe · Cited by 82
Self-citationPillai, S. K., Gold, H. S., Sakoulas, G., Wennersten, C. B., Moellering, R. C., & Eliopoulos, G. M. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00202-07 · Cited by 82
Rose, W. E., Leonard, S. N., Sakoulas, G., Kaatz, G. W., Zervos, M. J., Sheth, A., Carpenter, C. F., & Rybak, M. J. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00869-07 · Cited by 81
Self-citationGerber, P., Stucki, A. N., Acosta, F., Cottagnoud, M., & Cottagnoud, P. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl007 · Cited by 80
Safety and tolerability of linezolid in children
Saiman, L. M., Goldfarb, J., KAPLAN, S. A., Wible, K. L., EDGE-PADBURY, B., NABERHUIS-STEHOUWER, S., & BRUSS, J. B. (2003) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000087022.58089.d8 · Cited by 79
Self-citationFine-needle aspiration biopsy in diagnosis of soft tissue infections
Lee, P. C., Turnidge, J. D., & McDonald, P. J. (1985) · Journal of Clinical Microbiology · doi:10.1128/jcm.22.1.80-83.1985 · Cited by 78
Linezolid and rifampin: Drug interaction contrary to expectations?
Egle, H., Trittler, R., Kümmerer, K., et al. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.01.020 · Cited by 78
Rose, W. E., Rybak, M. J., & Kaatz, G. W. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm170 · Cited by 78
Self-citationChiang, F.-Y., & Climo, M. W. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.9.3002-3004.2003 · Cited by 78
Credito, K. L., Lin, G., & Appelbaum, P. C. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01455-06 · Cited by 78
Trimethoprim/Sulfamethoxazole for Treatment of Severe Staphylococcus aureus Infections
Adra, M., & Lawrence, K. R. (2004) · Annals of Pharmacotherapy · doi:10.1345/aph.1d156 · Cited by 77
Rifampin Treatment of Prosthetic Valve Endocarditis Due to Staphylococcus epidermidis
Karchmer, A. W., Archer, G. L., & Dismukes, W. E. (1983) · Clinical Infectious Diseases · doi:10.1093/clinids/5.supplement_3.s543 · Cited by 77
Self-citationLeonard, S. N., Rossi, K., Newton, K. L., & Rybak, M. J. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn520 · Cited by 77
Self-citationJung, Y. J., Koh, Y., Hong, S., Chung, J. W., Choi, S., Kim, N. J., Kim, M., Choi, I. S., Han, S. Y., Kim, W.-D., et al. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181b9ecea · Cited by 76
Fortunov, R. M., Hultén, K. G., Hammerman, W. A., Mason, E. O., & Kaplan, S. L. (2007) · PEDIATRICS · doi:10.1542/peds.2007-0956 · Cited by 76
Self-citationYoong, P., & Pier, G. B. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910344107 · Cited by 74
Stevens, D. L., Wallace, R. J., Hamilton, S. M., & Bryant, A. E. (2006) · Clinical Infectious Diseases · doi:10.1086/500265 · Cited by 74
Wiese‐Posselt, M., Heuck, D., Draeger, A., Mielke, M. E. A., Witte, W., Ammon, A., & Hamouda, O. (2007) · Clinical Infectious Diseases · doi:10.1086/517503 · Cited by 73
Lobo, L. J., Reed, K. D., & Wunderink, R. G. (2010) · CHEST Journal · doi:10.1378/chest.09-1562 · Cited by 73
Dudley, M. N., Levitz, R. E., Quintiliani, R., Hickingbotham, J. M., & Nightingale, C. H. (1984) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.26.6.811 · Cited by 72
Necessity of a loading dose when using vancomycin in critically ill patients
Wang, J. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/47.2.246 · Cited by 71
Falagas, M. E., Bliziotis, I. A., & Fragoulis, K. N. (2007) · American Journal of Infection Control · doi:10.1016/j.ajic.2006.09.005 · Cited by 71
Vikram, H. R., Havill, N. L., Koeth, L. M., & Boyce, J. M. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.10.5384-5387.2005 · Cited by 71
Cha, R., Brown, W. J., & Rybak, M. J. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.12.3960-3963.2003 · Cited by 70
Self-citationMiró, J. M., García-de-la-Mària, C., Armero, Y., Soy, D., Moreno, A., del Río, A., Almela, M., Sarasa, M., Mestres, C. A., Gatell, J. M., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00051-09 · Cited by 69
Linezolid therapy for infective endocarditis
Muñoz, P., Rodríguez-Creixéms, M., Moreno, M., Marín, M., Ramallo, V., Bouza, E., & GAME Study Group (2007) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01585.x · Cited by 68
Hematologic effects of linezolid in young children
Meissner, H. C., Townsend, T. R., Wenman, W. M., et al. (2003) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000087021.20838.d9 · Cited by 68
Holmes, R. L., & Jorgensen, J. H. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00945-07 · Cited by 68
Alós, J.-I., García-Cañas, A., García-Hierro, P., & Salvanés, F. R. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn246 · Cited by 66
Tenover, F. C., Sinner, S. W., Segal, R. E., Huang, V., Alexandre, S. S., McGowan, J. E., & Weinstein, M. P. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.12.010 · Cited by 65
Central nervous system invasion by community-acquired meticillin-resistant Staphylococcus aureus
Naesens, R., Ronsyn, M., Druwé, P., Denis, O., Ieven, M. M., & Jeurissen, A. (2009) · Journal of Medical Microbiology · doi:10.1099/jmm.0.011130-0 · Cited by 65
Sullenberger, A. L., Avedissian, L. S., & Kent, S. M. (2005) · PubMed · Cited by 64
Fitch, M. T., Manthey, D. E., McGinnis, H. D., Nicks, B. A., & Pariyadath, M. (2007) · New England Journal of Medicine · doi:10.1056/nejmvcm071319 · Cited by 63
Clinical Study of 44 Cases of Staphylococcus aureus Meningitis
Pintado, V., Meseguer, M. A., Fortün, J., Cobo, J., Navas, E., Quereda, C., Corral, I. P., & Moreno, S. (2002) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-002-0814-1 · Cited by 61
Treatment of Meningitis Caused by Methicillin-Resistant Staphylococcus aureus with Linezolid
Kessler, A., & Kourtis, A. P. (2007) · Infection · doi:10.1007/s15010-007-6211-z · Cited by 60
Successful Treatment of Methicillin‐ResistantStaphylococcus aureusMeningitis with Daptomycin
Lee, D. H., Palermo, B., & Chowdhury, M. (2008) · Clinical Infectious Diseases · doi:10.1086/590257 · Cited by 60
Whitman, T. J., Herlihy, R., Schlett, C. D., Murray, P. R., Grandits, G., Ganesan, A., Brown, M., Mancuso, J. D., Adams, W. B., & Tribble, D. R. (2010) · Infection Control and Hospital Epidemiology · doi:10.1086/657136 · Cited by 59
Chang, W. ‐., Lu, C., Wu, J.-J., Chang, H.-W., Tsai, Y. C., Chen, F., & Chien, C. (2001) · Infection · doi:10.1007/s15010-001-1092-z · Cited by 59
Steed, M. E., Vidaillac, C., & Rybak, M. J. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00536-10 · Cited by 57
Self-citationWysocki, M., THOMAS, F., Wolff, M., Pean, Y., Ravaud, Y., & HERMAN, B. (1995) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/35.2.352 · Cited by 57
Fox, P. M., Lampen, R. J., Stumpf, K. S., Archer, G. L., & Climo, M. W. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00232-06 · Cited by 54
Wright, C. T., Stocks, R. M. S., Armstrong, D. L., Arnold, S. R., & Gould, H. J. (2008) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.134.4.408 · Cited by 54
Linezolid for the treatment of complicated skin and skin structure infections in children
Yogev, R., Patterson, L. E. R., Kaplan, S. L., Adler, S. P., MORFIN, M. R., Martín, A., EDGE-PADBURY, B., NABERHUIS-STEHOUWER, S., & BRUSS, J. B. (2003) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000088671.35064.7c · Cited by 52
Self-citationSchwartz, B. S., Graber, C. J., Diep, B. A., Basuino, L., Perdreau‐Remington, F., & Chambers, H. F. “. (2009) · Clinical Infectious Diseases · doi:10.1086/598510 · Cited by 51
Self-citationHirschwerk, D. A., Ginocchio, C. C., Bythrow, M., & Condon, S. (2006) · Infection Control and Hospital Epidemiology · doi:10.1086/502688 · Cited by 50
Mason, E. O., Lamberth, L. B., Hammerman, W. A., Hultén, K. G., Versalovic, J. A., & Kaplan, S. L. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.00407-09 · Cited by 49
Self-citationRisk factors for Clostridium difficile toxin-positive nosocomial diarrhoea
Raveh, D., Rabinowitz, B., Breuer, G. S., Rudensky, B., & Yinnon, A. M. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.04.013 · Cited by 48
Kimura, A., Mochizuki, T., Nishizawa, K., Mashiko, K., Yamamoto, Y., & Otsuka, T. (1998) · doi:10.1097/00005373-199808000-00032 · Cited by 47
HYPOCHLORITE KILLING OF COMMUNITY-ASSOCIATED METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS
Fisher, R. G., Chain, R. L., Hair, P. S., & Cunnion, K. M. (2008) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e318175d871 · Cited by 47
Hyun, D. Y., Mason, E. O., Forbes, A., & Kaplan, S. L. (2008) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181826e5e · Cited by 47
Self-citationBaltch, A. L., Ritz, W. J., Bopp, L. H., Michelsen, P., & Smith, R. P. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01480-07 · Cited by 42
videos in clinical medicine Abscess Incision and Drainage
Fitch, M. T., Ph., D., Manthey, D. E., McGinnis, H. D., Nicks, B. A., Pariyadath, M., Medicine, P. O. E., Engl, N., & Med, J. (2014) · Cited by 42
Euba, G., Lora-Tamayo, J., Murillo, Ó., Pedrero, S., Cabo, J., Verdaguer, R., & Ariza, J. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00444-09 · Cited by 41
Loading dose of vancomycin in critically ill patients: 15mg/kg is a better choice than 500mg
Mohammédi, I., Descloux, É., Argaud, L., LESCANFF, J., & Robert, D. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2005.11.009 · Cited by 40
Amod, F. C., Moodley, I., Peer, A. K. C., Sunderland, J., Lovering, A. M., Wootton, M., NADVI, S., & Vawda, F. (2004) · Journal of Infection · doi:10.1016/j.jinf.2004.04.002 · Cited by 38
The surgical treatment of infective endocarditis
Mullany, C. J., McIsaacs, A. I., Rowe, M. H., et al. (1989) · World Journal of Surgery · doi:10.1007/bf01671175 · Cited by 35
Successful treatment of methicillin-resistant Staphylococcus aureus endocarditis with telavancin
Nace, H., & Lorber, B. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq113 · Cited by 33
The value of needle aspiration in the management of cellulitis.
Epperly, T. D. (1986) · PubMed · Cited by 31
Smith, P. F., Booker, B. M., Ogundele, A., et al. (2005) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2005.02.015 · Cited by 30
Sander, A., Beiderlinden, M., Schmid, E., & Peters, J. (2002) · Intensive Care Medicine · doi:10.1007/s00134-002-1358-7 · Cited by 29
Howe, R. A., Wootton, M., Noel, A. R., Bowker, K. E., Walsh, T. R., & MacGowan, A. P. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.11.3651-3652.2003 · Cited by 27
Wang, Q., Shi, Z., Wang, J., Shi, G., Wang, S., & Zhou, J. (2007) · Surgical Neurology · doi:10.1016/j.surneu.2007.01.073 · Cited by 27
Brown, E. L., Bowden, M. G., Bryson, R. S., Hultén, K. G., Bordt, A. S., Forbes, A., & Kaplan, S. L. (2008) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00360-08 · Cited by 25
Self-citationWootton, M. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf184 · Cited by 24
Steele, R. W., Russo, T. M., & Thomas, M. P. (2006) · Clinical Pediatrics · doi:10.1177/000992280604500306 · Cited by 24
Methicillin-resistant Staphylococcus aureus in community-acquired meningitis
von Specht, M., Gardella, N., Tagliaferri, P., Gutkind, G., & Mollerach, M. E. (2006) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-006-0124-0 · Cited by 20
Adults with Meningitis Caused by Oxacillin-Resistant Staphylococcus aureus
Lu, C.-H., & Chang, W. (2000) · Clinical Infectious Diseases · doi:10.1086/314034 · Cited by 20
Purcell, K., Fergie, J., & Peterson, M. D. (2006) · Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000199304.68890.60 · Cited by 19
Broder, K. W., Moise, P. A., Schultz, R. O., Forrest, A., & Schentag, J. J. (2004) · Annals of Plastic Surgery · doi:10.1097/01.sap.0000106888.60963.18 · Cited by 17
Schwalm, J.-D., El-Helou, P., & Lee, C. H. (2004) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2004/768765 · Cited by 16
Gallagher, R., Pizer, B. L., Ellison, J. A., & Riordan, F. A. I. (2008) · Journal of Infection · doi:10.1016/j.jinf.2008.06.023 · Cited by 16
Lacy, M. K., Tessier, P. R., Nicolau, D. P., Nightingale, C. H., & Quintiliani, R. (2000) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(00)00121-7 · Cited by 16
Value of needle aspiration in the management of cellulitis
Epperly, T. D. (1988) · U.S. Army Academy of Health Sciences, Stimson Library · Cited by 15
A Case of Spontaneous Methicillin‐Resistant Staphylococcus aureus Meningitis in a Health Care Worker
Dylewski, J. S., & Martel, G. (2004) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2004/125983 · Cited by 11
Open‐Access World Wide Web Resources on Sepsis
Fragoulis, K. N., Michalopoulos, A. S., & Falagas, M. E. (2008) · Clinical Infectious Diseases · doi:10.1086/590256 · Cited by 10
In Vitro Antagonism with the Combination of Vancomycin and Clindamycin Against Staphylococcus aureus
Booker, B. M., & Smith, P. F. (2004) · Cited by 9
Research works printed but not linked: 62
- Centers for Disease Control and Prevention, 2007, Severe methicillin-resistant Staphylococcus aureus community-acquired pneumonia associated with influenza–Louisiana Georgia, December 2006-January 2007, MMWR Morb Mortal Wkly Rep, 56, 325
- 1979, Canadian Task Force on the Periodic Health Examination, Can Med Assoc J, 121, 1193
- Nicholas, 1975, Concentration of clindamycin in human bone, Antimicrob Agents Chemother, 8, 220, 10.1128/AAC.8.2.220 · doi:10.1128/aac.8.2.220
- Joiner, 1981, Antibiotic levels in infected and sterile subcutaneous abscesses in mice, J Infect Dis, 143, 487, 10.1093/infdis/143.3.487 · doi:10.1093/infdis/143.3.487
- Panzer, 1972, Clindamycin levels in various body tissues and fluids, J Clin Pharmacol New Drugs, 12, 259, 10.1002/j.1552-4604.1972.tb00052.x · doi:10.1002/j.1552-4604.1972.tb00052.x
- Miller, 2010, Acute eosinophilic pneumonia secondary to daptomycin: a report of three cases, Clin Infect Dis, 50, e63, 10.1086/652656 · doi:10.1086/652656
- Abdel-Rahman, 2008, Single-dose pharmacokinetics of daptomycin in children with suspected or proved gram-positive infections, Pediatr Infect Dis J, 27, 330, 10.1097/INF.0b013e318160edfc · doi:10.1097/inf.0b013e318160edfc
- Loeffler, 2002, Safety and efficacy of quinupristin/dalfopristin for treatment of invasive gram-positive infections in pediatric patients, Pediatr Infect Dis J, 21, 950, 10.1097/00006454-200210000-00013 · doi:10.1097/00006454-200210000-00013
- Norden, 1986, Chronic osteomyelitis caused by Staphylococcus aureus: controlled clinical trial of nafcillin therapy and nafcillin-rifampin therapy, South Med J, 79, 947, 10.1097/00007611-198608000-00008 · doi:10.1097/00007611-198608000-00008
- Saravolatz, 2009, Telavancin: a novel lipoglycopeptide, Clin Infect Dis, 49, 1908, 10.1086/648438 · doi:10.1086/648438
- Sanchez, 1997, Cotrimoxazole plus rifampicin in the treatment of staphylococcal osteoarticular infection, Enferm Infecc Microbiol Clin, 15, 10
- Cooper, 1986, Pharmacokinetics of vancomycin. Vancomycin: a comprehensive review of 30 years clinical experience, 23
- d'Oliveira, 2003, Antimicrobial susceptibility and survey of macrolide resistance mechanisms among Streptococcus pyogenes isolated in Rio de Janeiro, Brazil, Microb Drug Resist, 9, 87, 10.1089/107662903764736382 · doi:10.1089/107662903764736382
- Libertin, 1983, Effects of trimethoprim-sulfamethoxazole and incubation atmosphere on isolation of group A streptococci, J Clin Microbiol, 18, 680, 10.1128/JCM.18.3.680-682.1983 · doi:10.1128/jcm.18.3.680-682.1983
- Trickett, 1973, Clinical experience: respiratory tract. Trimethoprim-sulfamethoxazole versus penicillin G in the treatment of group A beta-hemolytic streptococcal pharyngitis tonsillitis, J Infect Dis, 128, 693, 10.1093/infdis/128.Supplement_3.S693 · doi:10.1093/infdis/128.supplement_3.s693
- Tayal, 2006, The effect of soft-tissue ultrasound on the management of cellulitis in the emergency department, Acad Emerg Med, 13, 384, 10.1197/j.aem.2005.11.074 · doi:10.1197/j.aem.2005.11.074
- Squire, 2005, ABSCESS: applied bedside sonography for convenient evaluation of superficial soft tissue infections, Acad Emerg Med, 12, 601, 10.1197/j.aem.2005.01.016 · doi:10.1197/j.aem.2005.01.016
- Fleisher, 1980, Cellulitis: a prospective study, Ann Emerg Med, 9, 246, 10.1016/S0196-0644(80)80380-5 · doi:10.1016/s0196-0644(80)80380-5
- Fleisher, 1980, Cellulitis: bacterial etiology, clinical features, and laboratory findings, J Pediatr, 97, 591, 10.1016/S0022-3476(80)80014-X · doi:10.1016/s0022-3476(80)80014-x
- Newell, 1988, Value of needle aspiration in bacteriologic diagnosis of cellulitis in adults, J Clin Microbiol, 26, 401, 10.1128/JCM.26.3.401-404.1988 · doi:10.1128/jcm.26.3.401-404.1988
- Centers for Disease Control Prevention, Environmental cleaning & disinfecting for MRSA: what's the difference between cleaners, sanitizers, and disinfectants? 2010
- American Academy of Pediatrics, Antibacterial Drugs for Newborn Infantsl
- Wendt, 2007, Value of whole-body washing with chlorhexidine for the eradication of methicillin-resistant Staphylococcus aureus: a randomized, placebo-controlled, double-blind clinical trial, Infect Control Hosp Epidemiol, 28, 1036, 10.1086/519929 · doi:10.1086/519929
- Washington University School of Medicine, Staphylococcus aureus decolonization study (SuDS) (NCT00731783)
- Natividad Medical Center, A prospective trial of nasal mupirocin, hexachlorophene body Wash, systemic antibiotics for prevention of recurrent methicillin resistant staphylococcus aureus infections (NCT01049438)
- Los Angeles Biomedical Research Institute, A randomized clinical trial to prevent recurrent CA-MRSA infection (PRIMO) (NCT00560599)
- Chandorkar, 2009, Pharmacokinetics (PK) and safety of 8 and 10 mg/kg of daptomycin in pediatric patients aged 2 to 6 years. [abstract number 1243]
- Boucher, 2006, Appropriateness of two-week therapy for catheter-related S. aureus bacteremia [abstract number L-1204]
- Conte, 2002, Intrapulmonary pharmacokinetics of linezolid, Antimicrob Agents Chemother, 46, 1475, 10.1128/AAC.46.5.1475-1480.2002 · doi:10.1128/aac.46.5.1475-1480.2002
- Daver, 2007, Oral step-down therapy is comparable to intravenous therapy for Staphylococcus aureus osteomyelitis, J Infect, 54, 539, 10.1016/j.jinf.2006.11.011 · doi:10.1016/j.jinf.2006.11.011
- Al-Nammari, 2007, Hematogenous methicillin-resistant Staphylococcus aureus spondylodiscitis, Spine (Phila Pa 1976), 32, 2480, 10.1097/BRS.0b013e318157393e · doi:10.1097/brs.0b013e318157393e
- Van der Auwera, 1985, Double-blind, placebo-controlled study of oxacillin combined with rifampin in the treatment of staphylococcal infections, Antimicrob Agents Chemother, 28, 467, 10.1128/AAC.28.4.467 · doi:10.1128/aac.28.4.467
- Priest, 2005, Hematogenous vertebral osteomyelitis due to Staphylococcus aureus in the adult: clinical features and therapeutic outcomes, South Med J, 98, 854, 10.1097/01.smj.0000168666.98129.33 · doi:10.1097/01.smj.0000168666.98129.33
- Crompton, 2009, Safety and efficacy of daptomycin in the treatment of osteomyelitis: results from the CORE Registry, J Chemother, 21, 414, 10.1179/joc.2009.21.4.414 · doi:10.1179/joc.2009.21.4.414
- Shipton, 2007, Experience with daptomycin in Staphylococcus bone and joint infections: case series and emergence of nonsusceptibility, Infect Dis Clin Pract, 15, 324, 10.1097/IPC.0b013e318142cbbf · doi:10.1097/ipc.0b013e318142cbbf
- Chen, 2007, Experience with linezolid therapy in children with osteoarticular infections, Pediatr Infect Dis J, 26, 985, 10.1097/INF.0b013e31812e62dc · doi:10.1097/inf.0b013e31812e62dc
- Rao, 2007, Efficacy and safety of linezolid for gram-positive orthopedic infections: a prospective case series, Diagn Microbiol Infect Dis, 59, 173, 10.1016/j.diagmicrobio.2007.04.006 · doi:10.1016/j.diagmicrobio.2007.04.006
- Simpson, 2001, Chronic osteomyelitis. The effect of the extent of surgical resection on infection-free survival, J Bone Joint Surg Br, 83, 403, 10.1302/0301-620X.83B3.0830403 · doi:10.1302/0301-620x.83b3.0830403
- Aboltins, 2007, Treatment of staphylococcal prosthetic joint infections with debridement, prosthesis retention and oral rifampicin and fusidic acid, Clin Microbiol Infect, 13, 586, 10.1111/j.1469-0691.2007.01691.x · doi:10.1111/j.1469-0691.2007.01691.x
- Zalavras, 2009, Infection following operative treatment of ankle fractures, Clin Orthop Relat Res, 467, 1715, 10.1007/s11999-009-0743-8 · doi:10.1007/s11999-009-0743-8
- Ballock, 2009, A comparison of early versus late conversion from intravenous to oral therapy in the treatment of septic arthritis, J Pediatr Orthop, 29, 636, 10.1097/BPO.0b013e3181b2b860 · doi:10.1097/bpo.0b013e3181b2b860
- Jorgenson, 2007, Vancomycin disposition and penetration into ventricular fluid of the central nervous system following intravenous therapy in patients with cerebrospinal devices, Pediatr Neurosurg, 43, 449, 10.1159/000108786 · doi:10.1159/000108786
- Myrianthefs, 2006, Serum and cerebrospinal fluid concentrations of linezolid in neurosurgical patients, Antimicrob Agents Chemother, 50, 3971, 10.1128/AAC.00051-06 · doi:10.1128/aac.00051-06
- Beer, 2007, Pharmacokinetics of intravenous linezolid in cerebrospinal fluid and plasma in neurointensive care patients with staphylococcal ventriculitis associated with external ventricular drains, Antimicrob Agents Chemother, 51, 379, 10.1128/AAC.00515-06 · doi:10.1128/aac.00515-06
- Nagashima, 2008, Effect of linezolid against postneurosurgical meningitis caused by methicillin-resistant Staphylococcus epidermidis: case report, J Infect Chemother, 14, 147, 10.1007/s10156-007-0582-Z · doi:10.1007/s10156-007-0582-z
- Ntziora, 2007, Linezolid for the treatment of patients with central nervous system infection, Ann Pharmacother, 41, 296, 10.1345/aph.1H307 · doi:10.1345/aph.1h307
- Vartzelis, 2005, Brain abscesses complicating Staphylococcus aureus sepsis in a premature infant, Infection, 33, 36, 10.1007/s15010-005-4062-z · doi:10.1007/s15010-005-4062-z
- Schreffler, 2002, Treatment of cerebrospinal fluid shunt infections: a decision analysis, Pediatr Infect Dis J, 21, 632, 10.1097/00006454-200207000-00006 · doi:10.1097/00006454-200207000-00006
- Whitehead, 2001, The treatment of cerebrospinal fluid shunt infections. Results from a practice survey of the American Society of Pediatric Neurosurgeons, Pediatr Neurosurg, 35, 205, 10.1159/000050422 · doi:10.1159/000050422
- Sacar, 2006, A retrospective study of central nervous system shunt infections diagnosed in a university hospital during a 4-year period, BMC Infect Dis, 6, 43, 10.1186/1471-2334-6-43 · doi:10.1186/1471-2334-6-43
- Elvy, 2008, Treatment of external ventricular drain-associated ventriculitis caused by Enterococcus faecalis with intraventricular daptomycin, J Antimicrob Chemother, 61, 461, 10.1093/jac/dkm501 · doi:10.1093/jac/dkm501
- Ho, 1986, In vitro evaluation of clindamycin in combination with oxacillin, rifampin, or vancomycin against Staphylococcus aureus, Diagn Microbiol Infect Dis, 4, 133, 10.1016/0732-8893(86)90147-1 · doi:10.1016/0732-8893(86)90147-1
- Yanagisawa, 2007, Neutralization of staphylococcal exotoxins in vitro by human-origin intravenous immunoglobulin, J Infect Chemother, 13, 368, 10.1007/s10156-007-0551-6 · doi:10.1007/s10156-007-0551-6
- Ebert, 1987, In vivo cidal activity and pharmacokinetic parameters for vancomycin against methicillin-susceptible and resistant S. aureus [abstract 439]
- Dudley, 1999, Pharmacokinetic-pharmacodynamic indices for vancomycin treatment of susceptible intermediate S. aureus in the neutropenic murine thigh model [abstract 2031]
- Moise, 2000, Area under the inhibitory curve and a pneumonia scoring system for predicting outcomes of vancomycin therapy for respiratory infections by Staphylococcus aureus, Am J Health Syst Pharm, 57, S4, 10.1093/ajhp/57.suppl_2.S4 · doi:10.1093/ajhp/57.suppl_2.s4
- Lee-Such, 2006, Nephrotoxicity associated with aggressive vancomycin therapy [abstract #1298]
- Odio, 1984, Nephrotoxicity associated with vancomycin-aminoglycoside therapy in four children, J Pediatr, 105, 491, 10.1016/S0022-3476(84)80036-0 · doi:10.1016/s0022-3476(84)80036-0
- Kullar, 2009, High-dose daptomycin for complicated gram-positive infections [poster # 1984]
- Gebhart, 2007, Decreased serum linezolid levels in a critically ill patient receiving concomitant linezolid rifampin, Pharmacotherapy, 27, 476, 10.1592/phco.27.3.476 · doi:10.1592/phco.27.3.476
- Tan, 1993, Use of intravenous rifampin in neonates with persistent staphylococcal bacteremia, Antimicrob Agents Chemother, 37, 2401, 10.1128/AAC.37.11.2401 · doi:10.1128/aac.37.11.2401
- Deville, 2003, Linezolid versus vancomycin in the treatment of known or suspected resistant gram-positive infections in neonates, Pediatr Infect Dis J, 22, S158, 10.1097/01.inf.0000086955.93702.c7 · doi:10.1097/01.inf.0000086955.93702.c7
Cited by
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4683-6 · Cited by 6,621
Tong, S. Y. C., Davis, J. S., Eichenberger, E., Holland, T. L., & Fowler, V. G. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00134-14 · Cited by 5,192
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000923 · Cited by 3,686
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002255 · Cited by 3,652
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.02.536 · Cited by 3,523
Metadata
- Authors
- Liu, C., Bayer, A., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., Rybak, M. J., Talan, D. A., & Chambers, H. F.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-02-01
- Volume
- 52
- Issue
- 3
- Pages
- e18-e55
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2108433768
- Cited by
- 4,191
- References
- 317
- FWCI
- 199.81
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.